Gabriele M Cerrone bought $78k of ACUT
director, owner at Accustem Sciences Inc.. 152,802 shares at an average of $0.51, traded Mar 18, 2025, filed Apr 8, 2025.
Score components
- +15RoleDirector
- +9Trade size$78k at market
- 0Relative to holdingsHoldings up 3.2%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.2%, 3m +59.7%, 6m +130.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-003222, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2025 | POpen-market purchase Common Stockindirect: Via Panetta Partners Limited | +100,000 | $0.45 | $45k | 4,819,957 | Apr 8, 2025 |
| Apr 7, 2025 | POpen-market purchase Common Stockindirect: Via Panetta Partners Limited | +17,802 | $0.61 | $11k | 4,837,759 | Apr 8, 2025 |
| Apr 7, 2025 | POpen-market purchase Common Stockindirect: Via Panetta Partners Limited | +35,000 | $0.65 | $23k | 4,872,759 | Apr 8, 2025 |
Related signals
Other insiders at Accustem Sciences Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | ACUTbuy Accustem Sciences Inc. | Gabriele M Cerrone director, owner | $2,440 2,400 shares | +0% | |
| 15Weak | ACUTbuy Accustem Sciences Inc. | Gabriele M Cerrone director, owner | $18k 37,196 shares | +1% | |
| 20Weak | ACUTbuy Accustem Sciences Inc. | Gabriele M Cerrone director, owner | $25k 38,000 shares | +1% | |
| 21Weak | ACUTbuy Accustem Sciences Inc. | Gabriele M Cerrone director, owner | $38k 100,000 shares | +2% | |
| 33Weak | ACUTbuy Accustem Sciences Inc. | Gabriele M Cerrone director, owner | $5,295 3,729 shares | +0% | |
| 33Weak | ACUTbuy Accustem Sciences Inc. | Gabriele M Cerrone director, owner | $26k 24,500 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.